Jing Wei

Chengdu, 610064, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

PD-L1-targeted OMV priming licenses myeloid co-stimulation and chemokine circuits to potentiate CAR-T therapy in advanced-stage solid tumors.

PD-L1-targeted OMV priming licenses myeloid co-stimulation and chemokine circuits to potentiate CAR-T therapy in advanced-stage solid tumors.

Journal: Journal of nanobiotechnology

Published: March 23, 2026

XELOX combined with sintilimab and hyperbaric oxygen therapy for advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, single-arm, phase Ib/II clinical trial.

XELOX combined with sintilimab and hyperbaric oxygen therapy for advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, single-arm, phase Ib/II clinical trial.

Journal: Frontiers in immunology

Published: July 24, 2025

Single nucleotide polymorphisms of the Waxy gene and their relationship with the physicochemical properties of Pueraria lobata (kudzu) starch.

Single nucleotide polymorphisms of the Waxy gene and their relationship with the physicochemical properties of Pueraria lobata (kudzu) starch.

Journal: Carbohydrate polymers

Published: June 24, 2025

Structural and Biological Properties of Rhamnogalacturonan-I-Enriched Pectin Isolated from Cardamine tangutorum and Cardamine macrophylla.

Structural and Biological Properties of Rhamnogalacturonan-I-Enriched Pectin Isolated from Cardamine tangutorum and Cardamine macrophylla.

Journal: Foods (Basel, Switzerland)

Published: June 04, 2025

In vivo expression of CD3/CD19 bispecific T-cell engager and α-PD-L1-Fc enables effective and durable immunotherapy for CD19+/PD-L1+ leukemia.

In vivo expression of CD3/CD19 bispecific T-cell engager and α-PD-L1-Fc enables effective and durable immunotherapy for CD19+/PD-L1+ leukemia.

Journal: Leukemia

Published: May 22, 2025

Hyperbaric oxygen therapy as an immunosensitizing strategy in advanced gastric hepatoid adenocarcinoma: a case report.

Hyperbaric oxygen therapy as an immunosensitizing strategy in advanced gastric hepatoid adenocarcinoma: a case report.

Journal: Frontiers in immunology

Published: May 08, 2025

Fishbone ingestion is a non-negligible cause of intestinal perforation.

Fishbone ingestion is a non-negligible cause of intestinal perforation.

Journal: Frontiers in medicine

Published: April 07, 2025

Current Advances and Future Directions for Sensitizing Gastric Cancer to Immune Checkpoint Inhibitors.

Current Advances and Future Directions for Sensitizing Gastric Cancer to Immune Checkpoint Inhibitors.

Journal: Cancer medicine

Published: March 26, 2025

Cascade Promotion of Gas Separation Performances in CMS Membranes: MOFs With Functional Groups and Loaded Noble Metals.

Cascade Promotion of Gas Separation Performances in CMS Membranes: MOFs With Functional Groups and Loaded Noble Metals.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 24, 2025

Identification of GSK3 family and regulatory effects of brassinolide on growth and development of Nardostachys jatamansi

Identification of GSK3 family and regulatory effects of brassinolide on growth and development of Nardostachys jatamansi

Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica

Published: February 10, 2025

Turning Microstructure in Block Copolymer Membranes: A Facile Strategy to Improve CO2 Separation Performance.

Turning Microstructure in Block Copolymer Membranes: A Facile Strategy to Improve CO2 Separation Performance.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 21, 2025

Nab-paclitaxel combined with cadonilimab (AK104) as second-line treatment for advanced gastric cancer: protocol for a phase II prospective, multicenter, single-arm clinical trial.

Nab-paclitaxel combined with cadonilimab (AK104) as second-line treatment for advanced gastric cancer: protocol for a phase II prospective, multicenter, single-arm clinical trial.

Journal: Frontiers in immunology

Published: October 30, 2024

Showing 1-12 of 27

Last Updated: 09/26/2026